Phase 2 Urothelial Carcinoma Bladder Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Renal Retention in High Grade Upper Tract Urothelial Cancer
Bladder CancerUrothelial Carcinoma BladderHigh Grade Urothelial Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins20 enrolled2 locationsNCT05656235
Recruiting
Phase 2
Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy
Urothelial Carcinoma Bladder
University of Florida147 enrolled1 locationNCT06184516
Recruiting
Phase 1Phase 2
Intervention of Bladder Cancer by CAR-T
Bladder CancerUrothelial Carcinoma Bladder
Shenzhen Geno-Immune Medical Institute20 enrolled2 locationsNCT03185468
Recruiting
Phase 2
Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma
Urothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and UreterUrothelial Carcinoma Urethra+1 more
Nagoya University43 enrolled1 locationNCT06983210
Recruiting
Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Bladder CancerUrothelial Carcinoma BladderSmall Cell Neuroendocrine Carcinoma of Bladder
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins63 enrolled2 locationsNCT05312671
Recruiting
Phase 2
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial CarcinomaUrothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Mabwell (Shanghai) Bioscience Co., Ltd.60 enrolled2 locationsNCT06823427